Healthcare & Life Sciences

USPTO Patent Grant: Lignin Solvation for Antimicrobial Therapeutics

The USPTO has granted a patent (US12582670B2) to the University of Florida Research Foundation, Inc. for a method of solvating lignin in aqueous buffers for use in antimicrobial therapeutics. The patent covers aqueous lignin solutions and their applications in treating microbial infections and forming antimicrobial products.

USPTO Patent US12582667B2 for Gastrointestinal Cancer Treatment

The USPTO has granted patent US12582667B2 to The Rockefeller University for compounds and methods to treat metastatic gastrointestinal cancer. The patent details a method involving suppressing the enzymatic activity of DHODH and/or decreasing creatine levels via suppression of the creatine transporter SLC6a8.

USPTO Patent Grant for Low Dose Therapeutic Treatment

The USPTO has granted patent US12582666B2 to Syqe Medical Ltd. for a low dose therapeutic treatment system. The patent covers a system for delivering predetermined amounts of THC, with specific limits on dosage and delivery time, utilizing a decision module and an inhaler device.

USPTO Patent Grant for Injectable Pharmaceutical Compositions by Zoetis

The USPTO has granted patent US12582662B2 to Zoetis Services LLC for injectable pharmaceutical compositions. The patent covers formulations including a cyclodextrin, a hydrophobic drug, a co-solvent, and a preservative, designed for effective preservation according to pharmacopoeia standards.

USPTO Grants Patent for RSV Inhibitors

The USPTO has granted a new patent (US12582661B2) to SHANGHAI ARK BIOPHARMACEUTICAL CO., LTD. for a class of respiratory syncytial virus (RSV) inhibitors. The patent, effective March 24, 2026, covers compounds with potential advantages in activity and in vivo exposure compared to existing treatments.

USPTO Patent Grant: Methods Treating Disorders Using CSFIR Inhibitors

The USPTO has granted patent US12582655B2 to Deciphera Pharmaceuticals, LLC for methods of treating cancers and other tumors using CSFIR inhibitors. The patent covers methods related to the proliferation, depletion, or repolarization of tumor-associated macrophages (TAMs).

USPTO Grants Patent for Idiopathic Pulmonary Fibrosis Treatment

The USPTO has granted a patent (US12582653B2) to BEIJING TIDE PHARMACEUTICAL CO., LTD. for a compound and method to treat idiopathic pulmonary fibrosis. The patent covers compounds represented by formula (I) and their pharmaceutically acceptable derivatives.

USPTO Patent for Hair Follicle Regeneration

The USPTO has granted Washington University a patent (US12582649B2) for compositions and methods for hair follicle regeneration using TRPV4 activating agents. The patent aims to treat hair loss conditions such as alopecia and telogen effluvium.

USPTO Patent Grant: Dopamine D3 Agonists for CNS Disorders

The USPTO has granted patent US12582648B2 to Bioprojet Pharma for a method of treating central nervous system disorders, including restless leg syndrome and neurodegenerative diseases, using dopamine D3 partial agonists. The patent details specific applications and classifications related to these therapeutic uses.

USPTO Patent US12582642B2 for Treating Bovine Papillomatosis

The USPTO has granted patent US12582642B2 to KINOPHARMA, INC. for a composition and method to treat bovine papillomatosis. The patent covers compounds represented by Formula (I) or their pharmaceutically acceptable salts.

USPTO Grants Patent for Sulfur Compound in Tumor Treatment

The USPTO has granted patent US12582641B2 to SHANGHAITECH UNIVERSITY for a sulfur-containing compound based on a glutarimide skeleton and its application in treating tumors. The patent filing date was February 25, 2020, and the grant date is March 24, 2026.

Donepezil Topical Formulation Patent for Intradermal Use

The USPTO has granted a patent (US12582637B2) to Arctic Therapeutics HF for a topical formulation of donepezil intended for intradermal application. The patent covers compositions and methods of use for this specific formulation.

USPTO Patent Granted for Cancer Treatment with ERK Inhibitors

The USPTO has granted a patent (US12582635B2) to Biomed Valley Discoveries, Inc. for methods of treating cancer with atypical BRAF mutations using ERK inhibitors. The patent covers compositions, methods for treatment, and identification of suitable patient populations.

USPTO Patent Grant for CAH Treatment Compound

The USPTO has granted patent US12582634B2 to Neurocrine Biosciences, Inc. for a compound and synthetic methods for treating congenital adrenal hyperplasia (CAH). The patent covers specific chemical structures and their preparation, aiming to provide new therapeutic options for this condition.

USPTO Patent Grant for Improving Kidney Function

The USPTO has granted patent US12582631B2 to Chinook Therapeutics, Inc. for methods of improving kidney function. The patent, which includes 36 claims, was filed on August 16, 2022, and granted on March 24, 2026.

USPTO Patent Grant: Dapansutrile for Breast Cancer Treatment

The USPTO has granted patent US12582628B2 to Olatec Therapeutics, Inc. for a method of treating breast cancer using dapansutrile, optionally in combination with a checkpoint inhibitor. The patent covers methods of treatment and has an effective date of March 24, 2026.

Nestle Patent for MCTs Improving Cognitive Function

The USPTO has granted Nestle a patent (US12582627B2) for MCT formulations designed to improve cognitive functions, such as memory and executive function, and to prevent or treat mild cognitive impairment (MCI). The patent specifies daily dosages and composition ratios of medium chain triglycerides, particularly octanoic acid.

USPTO Patent Grant: Composition for Improving Muscle Function

The USPTO has granted patent US12582623B2 to N.V. Nutricia for a composition comprising EPA, MA, and leucine. This composition is intended for the prevention and/or treatment of diseases involving muscle decline or for improving muscle function.

USPTO Glove Design Patent Grant USD1119165S1

The USPTO has granted a design patent (USD1119165S1) for a glove, with the patent assigned to HAND HELD PRODUCTS, INC. The patent was granted on March 24, 2026, based on a filing date of January 19, 2023.

USPTO Patent Grant: Reclosable underwear-type disposable article

The USPTO has granted patent US12582563B2 to ZUIKO CORPORATION for a reclosable underwear-type disposable article. The patent covers the design and manufacturing method for an article with flaps and touch fasteners that allow for re-engagement when worn.

USPTO Patent Grant: Self-extendable Pulmonary Artery Stent

The USPTO has granted patent US12582748B2 for a self-extendable pulmonary artery stent with a dry valve. The patent, assigned to P+F Products + Features GmbH, details a stent design with specific features for fixation and valve attachment, along with a delivery device.

USPTO Grants Patent for PTFE Coating Film on Stent

The USPTO has granted patent US12582512B2 to BCM CO., LTD. for a method of forming a PTFE coating film on a stent. The patent covers a method that can form the film regardless of stent shape, prevent peeling, and facilitate formation.

USPTO Grants Patent for Eye Drop Container

The USPTO has granted a design patent (USD1120304S1) for an eye drop container to ANY EYE LLC. The patent covers the ornamental design of the dispensing container, with inventors listed as Aram P. Najarian, Richard T. Najarian, and Andrew N. Seymour.

USPTO Patent Grant for Flexible Implants and Instruments

The USPTO has granted patent US12582534B2 for flexible implants and instruments, assigned to VB Spine US Opco LLC. The patent describes an implant body with a flexible pattern defined by multiple material segments with non-linear shapes.

USPTO Patent Grant: Therapeutic Lasers for Ophthalmology

The USPTO has granted patent US12582553B2 to Pulsemedica Corp. for a therapeutic laser system using spatial light modulation for treating ophthalmological conditions. The patent covers technology that allows a therapeutic laser to be focused on multiple target locations simultaneously.

USPTO Patent Grant for Sanitary Napkin Design

The United States Patent and Trademark Office (USPTO) has granted Design Patent USD1120305S1 for a sanitary napkin design to The Procter & Gamble Company. The patent was granted on March 24, 2026, based on a filing date of April 30, 2024.

USPTO Grants Absorbent Article Patent to Procter & Gamble

The USPTO has granted a design patent (USD1120306S1) for an absorbent article to The Procter & Gamble Company. The patent covers the ornamental design of the article, with a filing date of March 7, 2025, and an issue date of March 24, 2026.

USPTO Patent Grant - Bandage Design USD1120349S1

The USPTO has granted a design patent (USD1120349S1) for a bandage design to Henan Beilite Auto Parts Co., Ltd. The patent was filed on February 11, 2025, and granted on March 24, 2026. This grant pertains to the aesthetic appearance of the bandage.

USPTO Thumb Brace Patent Grant USD1120351S1

The USPTO has granted a design patent (USD1120351S1) for a thumb brace to SHENZHEN WEPROTEX TECHNOLOGY PRODUCT CO., LTD. The patent, which includes one claim, was filed on December 9, 2024, and granted on March 24, 2026. This grant signifies the official recognition of the design's novelty and non-obviousness.

USPTO Sleep Mask Design Patent Granted

The USPTO has granted a design patent (USD1120091S1) for a sleep mask, with an effective date of March 24, 2026. The patent was filed on May 28, 2024, by inventor Dongbin Qiu.

USPTO Patent US12582552B2: Radiant Exposure at Retina During Ophthalmic Procedure

The USPTO has granted patent US12582552B2 to Alcon Inc. for a system and method to determine radiant exposure at the retina during ophthalmic procedures. The patent describes a laser system that calculates radiant exposure based on the distance between the laser target and the retina.

USPTO Patent Grant for Eye Aqueous Drainage Devices

The USPTO has granted patent US12582551B2 to Iantrek, Inc. for methods and devices to increase aqueous drainage of the eye, specifically for treating glaucoma. The patent describes a trabeculorhexis technique that applies non-cutting shear and tension to tissue, aiming to reduce incisional bleeding and tissue damage.

USPTO Grants Patent for Ankle Joint Mobilisation Apparatus

The USPTO has granted a patent (US12582543B2) to Azzurro Training Ltd for an apparatus designed to mobilise the human ankle joint. The patent details an apparatus with a base and strap, incorporating specific protrusions for medial arch support to enhance foot stability during dorsiflexion.

USPTO Grants Patent for Therapeutic Gas Delivery Cart

The USPTO has granted a design patent (USD1120338S1) for a therapeutic gas delivery cart to Mallinckrodt Pharmaceuticals Ireland Limited. The patent, which covers the design of the cart, was granted on March 24, 2026, with a filing date of June 17, 2025.

USPTO Grants Patent for Intragastric Device

The USPTO has granted a patent for an intragastric device designed to restrict gastric capacity. The device, assigned to Servicio Cántabro De Salud Universidad De Cantabria, utilizes a neutral buoyancy principle with an inner core and an outer covering containing fluids at different pressures. This patent grant is a routine administrative action.

USPTO Patent for Medical Device Crimper by Medtronic

The USPTO has granted a new patent (US12582539B2) to Medtronic for a clamshell iris-style crimper designed for medical devices. The patent details an innovative mechanism for compressing expandable medical devices, featuring a handle-operated clamshell design that reduces chamber volume to achieve compression.

USPTO Patent Grant US12582538B2 for Expandable Devices

The USPTO has granted patent US12582538B2 for expandable devices and associated systems and methods. The patent, assigned to The Foundry, LLC, details a stent configured to be expanded within a body conduit of a human patient.

USPTO Patent Grant US12582537B2 for Stent

The USPTO has granted patent US12582537B2 to Boston Scientific Scimed, Inc. for a stent with improved deployment characteristics. The patent details a knitted stent design with specific cell arrangements and loop/rung row configurations, including both open and closed cells.

USPTO Patent Grant for Expandable Interbody Spacer

The USPTO has granted a patent (US12582533B2) for an integrated expandable interbody spacer designed for spinal fusion procedures. The patent was assigned to IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY and lists four inventors. The device allows for controlled adjustment of height during surgery.

USPTO Grants Patent for Dual Mobility Cup Reverse Shoulder Prosthesis

The USPTO has granted a patent (US12582532B2) for a dual mobility cup reverse shoulder prosthesis, assigned to the University of Maryland, College Park. The patent covers a novel prosthesis system designed to improve shoulder joint function.

USPTO Patent Grant US12582531B2 for Shoulder Implant Systems

The USPTO has granted patent US12582531B2 to Arthrosurface Incorporated for novel humeral and glenoid articular surface implant systems and methods for shoulder repair. The patent details specific design features for glenoid implants and baseplates, including fixation elements and channels for assembly.

USPTO Patent Grant US12582530B2 - Humeral Implant Component

The United States Patent and Trademark Office (USPTO) has granted patent US12582530B2 for a humeral implant component to WALDEMAR LINK GMBH & CO. KG. The patent, which includes an interface part for connecting components and a through hole for a fastener, was granted on March 24, 2026.

US Patent US12582529B2 for Sacroiliac Joint Stabilization Prostheses

The USPTO has granted US Patent US12582529B2 for sacroiliac joint stabilization prostheses to Tenon Medical, Inc. The patent describes prostheses designed for press-fitting into pilot openings to stabilize dysfunctional sacroiliac joints, featuring a pontoon shape with porous sections.

US Patent for Sacroiliac Joint Stabilization Systems

The USPTO has granted a new patent (US12582528B2) to Tenon Medical, Inc. for systems designed for minimally invasive sacroiliac joint stabilization. The patent covers specific instruments and assemblies for creating and fixating openings in the SI joint for prosthesis deployment.

USPTO Patent Grant for Triply Periodic Minimal Surface Implants

The USPTO has granted a patent to RESTOR3D, INC. for sheet-based triply periodic minimal surface (TPMS) implants designed to promote osseointegration. The patent covers novel gyroid architectures and selective laser melting techniques for improved mechanical performance and reduced defect formation in implants.

Medical Implant Device Patent Granted

The United States Patent and Trademark Office (USPTO) has granted patent US12582526B2 for a medical implant device to Statera Medical Inc. The patent covers systems and methods for evaluating a joint implant device, including specific mechanical components and their interactions.

USPTO Grants Implantable Mesh Patent to Warsaw Orthopedic, Inc.

The USPTO has granted patent US12582525B2 for an implantable mesh to Warsaw Orthopedic, Inc. The patent covers a mesh made from demineralized bone fibers mechanically entangled with non-bone fibers, intended for use at target bone tissue sites.

Heart Anchor Positioning Devices Patent Granted

The USPTO has granted a patent (US12582524B2) to BioVentrix, Inc. for heart anchor positioning devices, methods, and systems for treating congestive heart failure. The patent describes a device designed to engage and secure heart anchors to the heart wall, with a tension indicating mechanism.

USPTO Patent Grant: Durability and Particulate Testing System

The USPTO has granted patent US12582523B1 for a durability and particulate testing system and method for medical devices. The patent, assigned to DYNATEK LABS, INC., details a system for simulating the expected lifetime of synthetic structural heart devices.

USPTO Patent Grant: Valve Repair Clip with Automatic Locking

The USPTO has granted patent US12582522B2 to Evalve, Inc. for a mitral valve repair clip with an automatic locking mechanism. The patent details a device designed to prevent movement of a stud relative to a lock by engaging the shank, with locking engagement only possible when a specific angle between arms is below a predefined threshold.